| Product name | Recombinant SARS-CoV-2 Envelope Protein |
|---|---|
| Catalog No. | RP01263LQ |
| Description | Recombinant SARS-CoV-2(2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
| Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL. |
| Purity | > 95% by SDS-PAGE. |
| Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
| Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 250mM NaCl, 0.5%TritonX-100, pH 8.0.Contact us for customized product form or formulation. |
| Species | SARS-CoV-2 |
| Calculated MW | 11.02 kDa |
| Synonym | 2019-nCoV E protein; 2019-nCoV sM protein; Envelope protein; Env polyprotein; Envelope glycoprotein; env; COVID-19; E |
|---|---|
| Expression Host | E. coli |
| Tag | N-His&Avi |
| Gene ID |
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01263LQ? Please let us know so that we can cite the reference in this datasheet.
